164 related articles for article (PubMed ID: 28601320)
21. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats.
Koc A; Duru M; Ciralik H; Akcan R; Sogut S
Mol Cell Biochem; 2005 Oct; 278(1-2):79-84. PubMed ID: 16180092
[TBL] [Abstract][Full Text] [Related]
22. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury.
Tunc T; Uysal B; Atabek C; Kesik V; Caliskan B; Oztas E; Ersoz N; Oter S; Guven A
J Surg Res; 2009 Aug; 155(2):210-6. PubMed ID: 19505699
[TBL] [Abstract][Full Text] [Related]
23. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
24. The effects of erdosteine on lung injury induced by the ischemia-reperfusion of the hind-limbs in rats.
Sirmali M; Uz E; Sirmali R; Kilbaş A; Yilmaz HR; Ağaçkiran Y; Altuntaş I; Delibaş N
J Surg Res; 2008 Apr; 145(2):303-7. PubMed ID: 17574582
[TBL] [Abstract][Full Text] [Related]
25. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of N-acetyl cysteine and erdosteine in rats with renal injury caused by paracetamol intoxication.
Kandiş H; Erkan ME; Yildirim U; Güneş H; Erbaş M; Yildirim HA; Gezer S; Kara IH
Hum Exp Toxicol; 2011 Sep; 30(9):1350-8. PubMed ID: 21115557
[TBL] [Abstract][Full Text] [Related]
27. Prevention of pulmonary complications of pneumoperitoneum in rats.
Karapolat S; Gezer S; Yildirim U; Dumlu T; Karapolat B; Ozaydin I; Yasar M; Iskender A; Kandis H; Saritas A
J Cardiothorac Surg; 2011 Feb; 6():14. PubMed ID: 21303502
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine.
Yildirim Z; Kotuk M; Iraz M; Kuku I; Ulu R; Armutcu F; Ozen S
Pulm Pharmacol Ther; 2005; 18(5):367-73. PubMed ID: 15939316
[TBL] [Abstract][Full Text] [Related]
29. Erdosteine against acetaminophen induced renal toxicity.
Isik B; Bayrak R; Akcay A; Sogut S
Mol Cell Biochem; 2006 Jul; 287(1-2):185-91. PubMed ID: 16532256
[TBL] [Abstract][Full Text] [Related]
30. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
31. Tissue-Protective Effect of Erdosteine on Multiple-Organ Injuries Induced by Fine Particulate Matter.
Cao L; Ping F; Zhang F; Gao H; Li P; Ning X; Cui G; Ma Z; Jiang X; Li S; Han S
Med Sci Monit; 2021 Dec; 27():e930909. PubMed ID: 34873140
[TBL] [Abstract][Full Text] [Related]
32. [The protective effects of intermedin 1-53 on oleic acid induced acute lung injury in rats].
Yu XM; Liu XM; Qi YF; Zhang ZG; Tang CS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):808-11. PubMed ID: 17327082
[TBL] [Abstract][Full Text] [Related]
33. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
34. An overview of erdosteine antioxidant activity in experimental research.
Moretti M; Marchioni CF
Pharmacol Res; 2007 Apr; 55(4):249-54. PubMed ID: 17267240
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant effect of erdosteine and lipoic acid in ovarian ischemia-reperfusion injury.
Dokuyucu R; Karateke A; Gokce H; Kurt RK; Ozcan O; Ozturk S; Tas ZA; Karateke F; Duru M
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():23-7. PubMed ID: 25461347
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the protective effect of erdosteine against cyclosporine-induced injury in rat liver with histological and biochemical methods.
Nacar A; Karaboğa I; Okuyan HM; Sefil NK; Nacar E; Motor S; Akküçük S; Ozkan OV
Turk J Med Sci; 2015; 45(6):1390-5. PubMed ID: 26775399
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
38. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
39. Effects of N-acetylcysteine on oxidant-antioxidant balance in oleic acid-induced lung injury.
Koksel O; Ozdulger A; Ercil M; Tamer L; Ercan B; Atik U; Cinel L; Cinel I; Kanik A
Exp Lung Res; 2004 Sep; 30(6):431-46. PubMed ID: 15524403
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of hydrogen-saturated saline on acute lung injury induced by oleic acid in rats.
Ying Y; Xu H; Yao M; Qin Z
J Orthop Surg Res; 2017 Sep; 12(1):134. PubMed ID: 28927460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
